

OCON Therapeutics
Company
|
Israel, Modiin-Maccabim-Reut
Primary tabs
About your organization / profile
OCON Therapeutics is a world-economic-forum technology pioneer tackling the most prevalent diseases and indications in women’s health addressing $35B markets. OCON designed a patent-protected 3D smart stent that delivers drugs to the uterus allowing safer, less-invasive, in-office procedures for indications such as heavy bleeding, fibroids, endometriosis & menopause. With a validated concept used in over 130K women, OCON is ready to expand its innovation globally.
Network (0)
There are no organizations in the network.
Recent activities

Schardinger Daniela (VP Marketing & Medical Affairs, OCON Therapeutics) has published an article on OCON Therapeutics's page.

The dataroom has been updated.